Speranza Therapeutics

speranza therapeutics distributes and clinically supports orphan drugs and medical devices, creating options for patients whose chronic illnesses are not being effectively addressed. our guiding principle is simple - to remove the inherent challenges in delivering treatment to patients in need through proven, clinically effective therapeutics and technology. s.t. genesis™ is the first speranza therapeutics innovation to hit the market. s.t. genesis is an fda-cleared percutaneous nerve field stimulator (pnfs), used as an aid to reduce the symptoms of opioid withdrawal. this powerful solution to the opioid crisis will partner with treatment centers, providing them with leading clinical technology, comprehensive protocols, patient support, and reimbursement services. to learn more about speranza therapeutics and our products, please visit our website: http://speranzatherapeutics.com/